Thrivent Financial For Lutherans Amicus Therapeutics, Inc. Transaction History

Thrivent Financial For Lutherans

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$9.97 - $14.52 $31,634 - $46,071	-3,173 Reduced 4.65%	64,999 $922,000
Q2 2023 Aug 14, 2023	SELL	$10.72 - $13.3 $35,847 - $44,475	-3,344 Reduced 4.68%	68,172 $856,000
Q1 2023 May 17, 2023	BUY	$10.91 - $13.54 $780,239 - $968,326	71,516 New	71,516 $793,000
Q3 2022 Nov 14, 2022	BUY	$9.82 - $12.75 $118,586 - $153,969	12,076 New	12,076 $126,000

313

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.69B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

Stay updated on Thrivent Financial For Lutherans with notifications on news.